Skip to content

EasyScreen™ Sample Processing Kit

by Genetic Signatures Ltd

Ref SP012

EasyScreen Sample Processing Kit (SP012) is a nucleic acid extraction/isolation kit IVD (EU IVDR Class A) made by Genetic Signatures Limited, registered in EUDAMED on 25 Mar 2024 (Basic UDI-DI 93511790SP012L7) and listed in FDA GUDID since 18 Nov 2024 (UDI-DI 09351179000003), active as of 25 Oct 2026.

Active European Union. Also listed in GUDID (US).

CE IVDR

Valid until

No date given

EUDAMED holds no validity date

FDA recalls

Not checked

No FDA submission to match recalls against

Documents

None, self-declared

Class I: no certifier involved

Trust

Unverified

Source EUDAMED, GUDID, synced 25 Oct 2026.

Regulatory status

as of registry sync 25 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesGUDID listing GUDID Number09351179000003 UDI-DI Date18 Nov 2024ListedStatusListed GUDID: in commercial distribution
European UnionCE/IVDR EUDAMED Number93511790SP012L7 Basic UDI-DI 09351179000003UDI-DIDate25 Mar 2024RegisteredStatusActive

Official records

From the FDA record

Device description
The EasyScreen™ Sample Processing Kit (SP012) is designed to rapidly isolate nucleic acids (DNA and RNA) from clinical samples via an automated purification system. Reagents are supplied to convert all nucleic acids into 3base™ sequences and to perform the subsequent purification on supported platforms (Genetic Signatures GS1). The purified nucleic acids are compatible with the EasyScreen™ Gastrointestinal Parasite Detection Kit (EP005). This kit includes all reagents required to take a sample from the specimen, lyse any microorganisms, convert the nucleic acid into 3base™ form and purify the nucleic acids using magnetic beads. This kit is designed to be used in hospital and pathology laboratories or similar by trained personnel. This kit does not produce any results, but it is a necessary requirement for the EasyScreen™ Gastrointestinal Parasite Detection Kit (EP005).
MRI safety
Labeling does not contain MRI Safety Information
Natural rubber latex
No latex statement on the label
Sterility
Supplied non-sterile

From the GUDID record (AccessGUDID), as read on 30 May 2026, as the labeller entered it.

Across registries

2 registries list this device

  • EUDAMED Basic UDI-DI 93511790SP012L7 registered 25 Mar 2024 Active
  • FDA GUDID UDI-DI 09351179000003 listed 18 Nov 2024 Listed

Certificates

0 certificates · EUDAMED

No certifier certificate is listed. Devices of this class are self-declared by the manufacturer.

Timeline

2 dated events

  1. Registered EUDAMED 93511790SP012L7
  2. Listed FDA GUDID 09351179000003

Coverage

2 jurisdictions

United States of AmericaSwedenFinlandLatviaEstoniaDenmarkLithuaniaIrelandNetherlandsGermanyPolandFranceBelgiumLuxembourgCzech RepublicSlovakiaAustriaHungaryRomaniaSloveniaBulgariaPortugalSpainItalyCroatiaGreeceMaltaCyprus
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered
  • European Union CE/IVDR Active
  • United States GUDID listing Listed

Specification

EUDAMED · GUDID

Generic name
Nucleic acid extraction/isolation kit IVD
Model / Ref / Catalog
SP012, 1
Primary DI / UDI-DI
09351179000003
Basic UDI-DI
93511790SP012L7
EMDN code
W0105900103 Supplemental na reagents
GMDN term
Nucleic acid extraction/isolation kit IVD
Device class
Class A
EU registration type
Standard device
EU market of registration
Greece
GUDID distribution status
In Commercial Distribution

Truth per registry

2 sources · 1 field differs

FieldEUDAMEDGUDID
Model / referenceEUDAMED
SP012
GUDID
1

Manufacturer details

EUDAMED SRN
AU-MF-000030901
Authorised representative
mdi Europa GmbH DE-AR-000006218

Similar devices in this category

Other devices filed under SUPPLEMENTAL NA REAGENTS.

Other devices from Genetic Signatures Limited

See all devices from Genetic Signatures Limited →

Properties

  • Single use
  • Reagent
  • IVD kit
  • Professional testing
  • Prescription use
  • Convenience kit
  • Premarket exempt
  • Lot / batch number
  • Expiration date
  • Manufacturing date
Other properties (16, all answered No)